Katherine I. Lin

Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells

Shilpee Dutt, Anupama Narla, Katherine I. Lin et al. · Blood · 2010 · 403 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease

James E. Bradner, Raymond H. Mak, Shyam Tanguturi et al. · Proceedings of the National Academy of Sciences · 2010 · 207 citations · Full text

Medicine, Hematology, Molecular Biology +15

Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non‐hodgkin lymphoma

Constantine S. Tam, Max Wolf, H. Miles Prince et al. · Cancer · 2006 · 94 citations

Medicine, Oncology, Pharmacotherapy +17

Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens

Katherine I. Lin, Constantine S. Tam, Michael J. Keating et al. · Blood · 2008 · 92 citations · Full text

Medicine, Hematology, Oncology +10

The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course

Constantine S. Tam, Lynne V. Abruzzo, Katherine I. Lin et al. · Blood · 2009 · 90 citations · Full text

Medicine, Hematology, Pathology +17